BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data at HFSA Annual Meeting
October 03, 2022 07:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Strataca Systems®, Ltd. Presents Data Demonstrating Improved Kidney Function Associated with JuxtaFlow® Renal Negative Pressure Treatment in Animal Models With and Without Congestive Heart Failure, Paving the Way For Human Clinical Trials
October 01, 2020 09:45 ET
|
3ive Labs
New Data Presented as Part of Moderated Poster Session at the Heart Failure Society of America Virtual Conference held September 30 – October 3, 2020 ROSWELL, Ga., Oct. 01, 2020 (GLOBE NEWSWIRE) --...